Robert Li is the founder of LTZ Therapeutics. LTZ Therapeutics has raised $130M in total funding. Latest round: Series A. Based in Palo Alto, California, US.
Robert Li is the Founder and CEO of LTZ Therapeutics, a clinical-stage immunotherapy biotechnology company he co-founded in 2022. The company focuses on developing Universal Myeloid Cell Engager (U-MCE™) therapies for oncology and autoimmune diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library